These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30930692)
1. High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-β pathway. Zhou K; Ou Q; Wang G; Zhang W; Hao Y; Li W Cancer Cell Int; 2019; 19():63. PubMed ID: 30930692 [TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p. Xu C; Zhu LX; Sun DM; Yao H; Han DX Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533 [TBL] [Abstract][Full Text] [Related]
3. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells. Geng Q; Li Z; Li X; Wu Y; Chen N J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335 [TBL] [Abstract][Full Text] [Related]
4. LncRNA NORAD promotes thyroid carcinoma progression by targeting miR-451. Shi L; Cong YZ; Wang ZJ Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6187-6195. PubMed ID: 34730199 [TBL] [Abstract][Full Text] [Related]
5. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1. Luo L; Chen C; He H; Cai M; Ling C Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway. Zhang Y; Li Y Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272 [TBL] [Abstract][Full Text] [Related]
7. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway. Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879 [TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA NORAD Inhibits Breast Cancer Cell Proliferation and Metastasis by Regulating miR-155-5p/SOCS1 Axis. Liu W; Zhou X; Li Y; Jiang H; Chen A J Breast Cancer; 2021 Jun; 24(3):330-343. PubMed ID: 34190442 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of long non-coding RNA NORAD promotes invasion and migration in malignant melanoma via regulating the MIR-205-EGLN2 pathway. Chen Y; Cao K; Li J; Wang A; Sun L; Tang J; Xiong W; Zhou X; Chen X; Zhou J; Liu Y Cancer Med; 2019 Apr; 8(4):1744-1754. PubMed ID: 30843652 [TBL] [Abstract][Full Text] [Related]
10. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic potential of long non-coding RNA NORAD in patients with acute deep vein thrombosis and its role in endothelial cell function. Zhou K; Li N; Qi J; Tu P; Yang Y; Duan H Thromb J; 2024 Jan; 22(1):3. PubMed ID: 38167080 [TBL] [Abstract][Full Text] [Related]
12. LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p. He H; Yang H; Liu D; Pei R Am J Transl Res; 2019; 11(1):290-299. PubMed ID: 30787987 [TBL] [Abstract][Full Text] [Related]
13. lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2. Mao W; Wang S; Chen R; He Y; Lu R; Zheng M Open Med (Wars); 2022; 17(1):1538-1549. PubMed ID: 36245705 [TBL] [Abstract][Full Text] [Related]
14. LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P. Tan BS; Yang MC; Singh S; Chou YC; Chen HY; Wang MY; Wang YC; Chen RH Oncogene; 2019 Jul; 38(28):5612-5626. PubMed ID: 30967631 [TBL] [Abstract][Full Text] [Related]
15. lncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p. Wang Y; Zhou B; Yan L; Wu J; Xing Z; Zhang S; Xiang F Exp Ther Med; 2021 Jun; 21(6):645. PubMed ID: 33968176 [TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608. Miao Z; Guo X; Tian L Gene; 2019 Mar; 687():116-124. PubMed ID: 30453063 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer. Huo H; Tian J; Wang R; Li Y; Qu C; Wang N Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219 [TBL] [Abstract][Full Text] [Related]
18. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma. Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-β signaling pathway. Wu ZJ; Li Y; Wu YZ; Wang Y; Nian WQ; Wang LL; Li LC; Luo HL; Wang DL Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):706-714. PubMed ID: 28272713 [TBL] [Abstract][Full Text] [Related]
20. Downregulated NORAD in neuroblastoma promotes cell proliferation via chromosomal instability and predicts poor prognosis. Yu Y; Chen F; Jin Y; Yang Y; Wang S; Zhang J; Chen C; Zeng Q; Han W; Wang H; Guo Y; Ni X Acta Biochim Pol; 2020 Dec; 67(4):595-603. PubMed ID: 33326736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]